| NVAX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the NVAX market cap history going back to 3/11/2010:
Also see: NVAX Shares Outstanding History and NVAX YTD Return |
NVAX Market Cap History — Novavax Capitalization Over Time
As of 4/30/2026 Novavax has a market cap of 1.30 billion. Investors often follow the NVAX market cap history to compare the size of the company over time.
This page shows NVAX market capitalization trends over time, with 69 market cap datapoints presented, dating back to 3/11/2010.
| NVAX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NVAX Historical Market Cap: +10.81% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NVAX Stock Price Chart |
| About Novavax, Inc. |
| Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. Co. offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). We show 69 historical shares outstanding datapoints in our NVAX shares outstanding history coverage, used to compute NVAX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing NVAX market cap history over the course of time is important for investors interested in comparing NVAX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of NVAX versus a peer is one thing; comparing NVAX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like NVAX can fluctuate over the course of history. With this page we aim to empower investors researching NVAX by allowing them to research the NVAX market cap history. |
| NVAX Current Stock Quote |
Quotes delayed 20 minutes  Free NVAX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| NVAX Share Performance |
| Market Cap Peers |
| Novavax (NVAX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
NVCT Market Cap History NVIV Market Cap History NVNO Market Cap History NVO Market Cap History NVOS Market Cap History NVRO Market Cap History NVST Market Cap History NVTA Market Cap History NVTR Market Cap History NVUS Market Cap History More Healthcare companies » |
NVAX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
